• In August 2026, Ingredion Incorporated reported second-quarter 2026 results showing sales of US$1,850 million, lower earnings per share versus the prior year, confirmed it had completed a US$77.82 million buyback of 673,000 shares under its existing program, and reaffirmed full-year 2026 EPS guidance of US$9.15 to US$9.75 despite expecting a low double-digit drop in reported operating income.
• The company expects full-year 2026 net sales to be flat to up low single digits, reflecting volume growth and favorable foreign exchange partly offset by lower price mix and the sale of its majority stake in its Pakistan business, while highlighting that Texture & Healthful Solutions volume growth and market share gains supported a constructive reaction to the quarter.
• Next, we will examine how reaffirmed full-year EPS guidance despite weaker operating income influences Ingredion’s existing investment narrative.

Rare earth metals are the new gold rush. Find out which 28 stocks are leading the charge.

Ingredion Investment Narrative Recap

To own Ingredion, you need to believe its shift toward higher value Texture & Healthful Solutions can offset pressures in legacy starches and sweeteners. The reaffirmed 2026 EPS range of US$9.15 to US$9.75, despite a low double digit decline in reported operating income, suggests the near term earnings catalyst is still intact. However, the sharp year over year EPS drop in the quarter keeps price and mix headwinds, and softer core demand, firmly in focus as key risks.

The most relevant recent announcement here is the completion of the US$77.82 million repurchase of 673,000 shares under the existing buyback program. While buybacks do not change Ingredion’s operational challenges, they interact with the EPS guidance by slightly reducing the share count, which can help support per share earnings even as reported operating income comes under pressure. For investors watching near term EPS delivery, this is a meaningful piece of the puzzle.

Yet while the Texture & Healthful Solutions story remains encouraging, investors should be aware that pressure on reported operating income and pricing could still...

Ingredion's narrative projects $7.8 billion revenue and $789.5 million earnings by 2029. This requires 2.5% yearly revenue growth and about a $115.5 million earnings increase from $674.0 million today.

Uncover how Ingredion's forecasts yield a $122.83 fair value, a 17% upside to its current price.

Exploring Other Perspectives

Some of the most pessimistic analysts were assuming roughly flat revenue near US$7.4 billion and earnings of about US$774 million by 2029, so you should expect that their already cautious view on margin pressure and operating income may shift again after this latest quarter and compare it with more optimistic takes on Ingredion’s earnings path.

Explore 5 other fair value estimates on Ingredion - why the stock might be worth 16% less than the current price!

Decide For Yourself

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Ingredion research is our analysis highlighting 4 key rewards that could impact your investment decision.
• Our free Ingredion research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Ingredion's overall financial health at a glance.

Curious About Other Options?

The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:

• Invest in the nuclear renaissance through our list of 91 elite nuclear energy infrastructure plays powering the global AI revolution.
• Capitalize on the AI infrastructure supercycle with our selection of the 55 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• This technology could replace computers: discover 24 stocks that are working to make quantum computing a reality.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.